Irvine, California — KB Medical Group (KBMED), a global leader in medical device innovation and manufacturing, has announced the expansion of its production capacity with a new Safety Pen-Type Blood Collection Needle (Model: SBCN-3)  line, scheduled to begin mass production in November 2025. This milestone marks a major investment in enhancing supply stability for Europe’s laboratory and hospital sectors, where the demand for safety-engineered blood collection devices continu

I n high-volume clinical settings, safety is not just a feature—it’s a requirement. That’s why at KBMED , we continue to align product...

Following a focused two-day business visit to El Salvador, Panda. W, Deputy Sales Manager and Regional Manager for North & South America,...

July 2025, We are proud to announce that KB Medical Group ( www.kbmed.com ) has completed a rigorous on-site audit conducted by the U.S....

June 2025 – KB Medical (KBMED) is proud to announce that it recently received a Canadian order for our specimen product line, as we...

R ecent developments in U.S. trade policy have significantly impacted Europe's medical disposable market. On April 9, 2025, President...

KB Medical Group  proudly announces that its blood collection tubes have successfully transitioned from the EU In Vitro Diagnostic...

In healthcare, color is more than just a visual expression—it’s an extension of care and comfort.In pediatric clinics, candy-colored...

W e are excited to announce that KB Medical Group will be showcasing our innovative solutions at MEDICA 2024 , the world’s leading...

We are excited to announce the launch of KBMED's Push Button Blood Collection Sets , now available in 21G, 23G, and 25G options, with or...

Claim your complimentary pass  to ADLM2024   ABOUT ADLM The Association for Diagnostics & Laboratory Medicine is a global scientific and...

Welcome to KBMED's weekly updates! We're excited to introduce our latest advance in medical disposable products: the enhanced needle for...

Thank you for joining us for our latest newsletter. We're thrilled to share some exciting news with you: KBMED's FDA 510K cleared vacuum...

We are pleased to share the latest business developments at KB Medical Group Inc. as we expand our presence into the veterinary...

Thank you for joining us for our latest newsletter. We're thrilled to share that KBMED is expanding its production capacity and...

I n the recent newsletter, we highlighted our business update in Germany , and our blood bag product line successfully passed a rigorous...

We hope everyone's week is off to a great start. We are delighted to share some exciting news regarding our product development. We have...

"KB Medical Group Inc. was newly awarded a contract in June by a Turkey-leading medical organization for a safety multi-sample needle and...

KB Medical Group Inc. was newly awarded the public hospital tender in Portugal. Under the contract, we will provide double, triple, and...

Even in the post-epidemic era, the sales and market demand for KB's safe blood collection needle series and related products have...